Document is current
Any future updates will be listed below
-
Authors
Berger, M E
Smesny, S
Kim, S-W
Davey, C G
Rice, S
Sarnyai, Z
Schlögelhofer, M
Schäfer, M R
Berk, M https://orcid.org/0000-0002-5554-6946
McGorry, P D
Amminger, G P
- License Information
-
More Information
Article History
Received: 2 April 2017
Revised: 8 June 2017
Accepted: 20 June 2017
First Online: 29 August 2017
Competing interests
: MB has received grant/research support from the NIH, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Rotary Health, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Meat and Livestock Board, Organon, Novartis, Mayne Pharma, Servier, and Woolworths, and has been a speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Merck, Pfizer, Sanofi Synthelabo, Servier, Solvay and Wyeth, and served as a consultant to Allergan, Astra Zeneca, Bioadvantex, Bionomics, Collaborative Medicinal Development, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck Merck, Pfizer, and Servier. The remaining authors declare no conflict of interest.
